A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]

Karina Meijer; E. B. Haagsma; The CHARIBDIS Study Group; J. Van Der Meer

doi:10.1111/j.1538-7836.2004.0562c.x

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]

Karina Meijer^*, E. B. Haagsma, The CHARIBDIS Study Group, J. Van Der Meer

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

9 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Pages (from-to)	194-196
Number of pages	3
Journal	Journal of Thrombosis and Haemostasis
Volume	2
Issue number	1
DOIs	https://doi.org/10.1111/j.1538-7836.2004.0562c.x
Publication status	Published - Jan 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1538-7836.2004.0562c.x

PIIS1538783622178098Final published version, 225 KB

Cite this

@article{e58846b8078b4870af063ad12c76c2aa,

title = "A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]",

author = "Karina Meijer and Haagsma, {E. B.} and {The CHARIBDIS Study Group} and {Van Der Meer}, J. and Kappers-Klunne, {M. C.} and Leebeek, {F. W.G.}",

year = "2004",

month = jan,

doi = "10.1111/j.1538-7836.2004.0562c.x",

language = "English",

volume = "2",

pages = "194--196",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Elsevier",

number = "1",

}

Meijer, K, Haagsma, EB, The CHARIBDIS Study Group & Van Der Meer, J 2004, 'A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]', Journal of Thrombosis and Haemostasis, vol. 2, no. 1, pp. 194-196. https://doi.org/10.1111/j.1538-7836.2004.0562c.x

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]. / Meijer, Karina; Haagsma, E. B.; The CHARIBDIS Study Group et al.
In: Journal of Thrombosis and Haemostasis, Vol. 2, No. 1, 01.2004, p. 194-196.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]

AU - Meijer, Karina

AU - Haagsma, E. B.

AU - The CHARIBDIS Study Group

AU - Van Der Meer, J.

AU - Kappers-Klunne, M. C.

AU - Leebeek, F. W.G.

PY - 2004/1

Y1 - 2004/1

UR - http://www.scopus.com/inward/record.url?scp=4444317171&partnerID=8YFLogxK

U2 - 10.1111/j.1538-7836.2004.0562c.x

DO - 10.1111/j.1538-7836.2004.0562c.x

M3 - Comment/Letter to the editor

C2 - 14717986

AN - SCOPUS:4444317171

SN - 1538-7933

VL - 2

SP - 194

EP - 196

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

IS - 1

ER -

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia [3]

UN SDGs

Access to Document

Other files and links

Cite this